Pictet Asset Management SA Purchases 41,170 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Pictet Asset Management SA grew its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 41.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 139,750 shares of the medical instruments supplier’s stock after acquiring an additional 41,170 shares during the period. Pictet Asset Management SA owned about 0.07% of DENTSPLY SIRONA worth $5,489,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of XRAY. MetLife Investment Management LLC raised its stake in DENTSPLY SIRONA by 23.1% in the first quarter. MetLife Investment Management LLC now owns 59,453 shares of the medical instruments supplier’s stock worth $2,926,000 after buying an additional 11,156 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in DENTSPLY SIRONA by 6.6% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 29,250 shares of the medical instruments supplier’s stock worth $1,440,000 after buying an additional 1,811 shares in the last quarter. Raymond James Trust N.A. raised its stake in DENTSPLY SIRONA by 61.7% in the first quarter. Raymond James Trust N.A. now owns 7,042 shares of the medical instruments supplier’s stock worth $346,000 after buying an additional 2,687 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in DENTSPLY SIRONA by 6.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,833,372 shares of the medical instruments supplier’s stock worth $90,243,000 after buying an additional 117,571 shares in the last quarter. Finally, Sei Investments Co. raised its stake in DENTSPLY SIRONA by 18.9% in the first quarter. Sei Investments Co. now owns 468,759 shares of the medical instruments supplier’s stock worth $23,090,000 after buying an additional 74,629 shares in the last quarter. 99.68% of the stock is owned by institutional investors.

DENTSPLY SIRONA Trading Up 0.7 %

NASDAQ:XRAY opened at $37.78 on Thursday. The company’s 50 day moving average price is $39.48 and its 200-day moving average price is $38.94. DENTSPLY SIRONA Inc. has a 52 week low of $26.48 and a 52 week high of $43.24. The company has a quick ratio of 0.99, a current ratio of 1.51 and a debt-to-equity ratio of 0.50. The stock has a market cap of $8.00 billion, a price-to-earnings ratio of -7.92, a PEG ratio of 2.15 and a beta of 0.93.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last posted its quarterly earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.08. DENTSPLY SIRONA had a negative net margin of 26.04% and a positive return on equity of 10.29%. The firm had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $998.98 million. The business’s revenue was up .5% on a year-over-year basis. On average, equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.97 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be issued a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a dividend yield of 1.48%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s payout ratio is -11.74%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on XRAY. Stifel Nicolaus increased their price target on shares of DENTSPLY SIRONA from $37.00 to $41.00 in a research note on Thursday, May 4th. StockNews.com began coverage on shares of DENTSPLY SIRONA in a research note on Thursday, August 17th. They issued a “buy” rating for the company. Robert W. Baird increased their price target on shares of DENTSPLY SIRONA from $36.00 to $46.00 in a research note on Thursday, May 4th. UBS Group upped their price objective on shares of DENTSPLY SIRONA from $43.00 to $46.00 in a report on Friday, May 5th. Finally, Barrington Research restated an “outperform” rating and issued a $51.00 price objective on shares of DENTSPLY SIRONA in a report on Friday, August 4th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $42.13.

View Our Latest Stock Report on XRAY

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

Featured Articles

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.